시장보고서
상품코드
1090022

세계의 마이크로니들형 인플루엔자 백신 시장 규모 : 제품 종류, 백신 종류, 지역별 예측(2022-2028년)

Global Microneedle Flu Vaccine Market Size study, by Product Type (Solid Microneedle, Hollow Microneedle, Coated Microneedle, Dissolving Microneedle), by Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine) and Regional Forecasts 2022-2028

발행일: | 리서치사: Bizwit Research & Consulting LLP | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 마이크로니들형 인플루엔자 백신 시장 규모는 예측기간인 2022-2028년에 5.2% 이상의 건전한 성장률로 확대될 것으로 예상됩니다.

시장 성장을 견인하는 주요 요인은 주요 기업이 마이크로니들형 인플루엔자 백신 연구개발에 주력하고 있는 점이나 인플루엔자나 바이러스 감염 유병률 증가 등을 들 수 있습니다. 향후 몇 년간은 질병 부담 증가가 시장 성장에 긍정적 영향을 미칠 것으로 예상됩니다. 그러나 마이크로니들 관련 합병증이나 위험은 2022-2028년 예측기간에 시장 성장을 저해할 것으로 생각됩니다.

세계의 마이크로니들형 인플루엔자 백신(Microneedle Flu Vaccine) 시장을 조사했으며, 시장 개요, 업계 분석, COVID-19에 의한 위험 평가, 백신 종류·제품 종류·지역별 분석 및 경쟁 정보 등을 제공합니다.

목차

제1장 주요 요약

제2장 세계의 마이크로니들형 인플루엔자 백신 시장 : 정의와 범위

제3장 세계의 마이크로니들형 인플루엔자 백신 시장 : 시장 역학

  • 마이크로니들형 인플루엔자 백신 시장 : 영향 분석(2020-2028년)

제4장 세계의 마이크로니들형 인플루엔자 백신 시장 : 업계 분석

  • Porter's Five Forces 모델
  • PEST 분석
  • 투자 채용 모델
  • 애널리스트의 추천사항과 결론
  • 주요 투자 기회
  • 주요 성공 전략

제5장 위험 평가 : COVID-19의 영향

    • 업계에 대한 COVID-19의 전체적 영향 평가
    • COVID-19 이전·이후 시장 시나리오

제6장 세계의 마이크로니들형 인플루엔자 백신 시장 : 백신 종류별

  • 시장 현황
  • 실적 - 잠재적 분석
  • 추정·예측(2018-2028년)
  • 하위 부문 분석
    • 3가 인플루엔자 백신
    • 4가 인플루엔자 백신

제7장 세계의 마이크로니들형 인플루엔자 백신 시장 : 제품 종류별

  • 시장 현황
  • 실적 - 잠재적 분석
  • 추정·예측(2018-2028년)
  • 하위 부문 분석
    • 고체 마이크로니들
    • 중공 마이크로니들
    • 피복 마이크로니들
    • 용해 마이크로니들

제8장 세계의 마이크로니들형 인플루엔자 백신 시장 : 지역별 분석

  • 지역별 시장 현황
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
  • 기타 지역

제9장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • Becton, Dickinson and Company
    • 3M Company
    • CosMED Pharmaceuticals Co., Ltd.
    • OraSure Technologies, Inc.
    • NanoPass Technologies Limited
    • Corium International, Inc
    • FluGen, Inc.
    • Microdermics
    • Debiotech S.A

제10장 조사 과정

KSM 22.06.29

Global Microneedle Flu Vaccine Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2022-2028. Micro-needles are a novel sort of dosing device that may easily overcome the problems that older formulations face. Micron-sized needles are put on a tiny dermal patch to create the microneedle device. Solid micro-needles, coated micro-needles, hollow micro-needles, dissolving micro-needles, solid are only a few of the several types of micro-needles available. The market growth is driven by key factors such as key players focusing on research and development of Micro-Needle Flu Vaccines and increasing prevalence of influenza and viral infections. For instance, Verndari, Inc received USD 1 million in funding from the US Government Agency BARDA in August 2020 to help accelerate the research and development of VaxiPatch, a dermal patch vaccination technology that may be used to treat a variety of infectious illnesses including influenza flu. Furthermore, according to statistics published by MedAlertHelp, around 5% to 20% of Americans will be diagnosed with influenza each year in 2022. In addition, according to data released by the Centers for Disease Control and Prevention in October 2021, the 2019-2020 flu season resulted in 35 million flu-related illnesses, 380,000 flu-related hospitalizations, 20,000 flu-related fatalities, and 16 million flu-related medical visits. Over the next several years, the increased burden of illnesses is expected to have a favorable influence on market growth. However, complications and risks associated with Microneedles impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Microneedle Flu Vaccine Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific is dominating the market owing to increasing clinical development of microneedle flu vaccines. However, North America is projected to be the fastest growing region due to the launch of new campaigns and initiatives by healthcare agencies to prevent the flu.

Major market players included in this report are:

Becton, Dickinson and Company

3M Company

CosMED Pharmaceuticals Co., Ltd.

OraSure Technologies, Inc.

NanoPass Technologies Limited

Corium International, Inc

FluGen, Inc.

Microdermics

Debiotech S.A

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Solid Microneedle

Hollow Microneedle

Coated Microneedle

Dissolving Microneedle

By Vaccine Type:

Trivalent Flu Vaccine

Quadrivalent Flu Vaccine

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Microneedle Flu Vaccine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Microneedle Flu Vaccine Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Microneedle Flu Vaccine Market, by Product Type, 2020-2028 (USD Million)
    • 1.2.3. Microneedle Flu Vaccine Market, by Vaccine Type, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Microneedle Flu Vaccine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Microneedle Flu Vaccine Market Dynamics

  • 3.1. Microneedle Flu Vaccine Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Key Players Focusing on Research and Development of Micro-Needle Flu Vaccines
      • 3.1.1.2. Increasing Prevalence of Influenza and Viral Infections
    • 3.1.2. Market Challenges
      • 3.1.2.1. Complications and Risks Associated with Microneedles
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising incidences of swine flu
      • 3.1.3.2. increased risk of respiratory diseases and immune-deficient diseases

Chapter 4. Global Microneedle Flu Vaccine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Microneedle Flu Vaccine Market, by Vaccine Type

  • 6.1. Market Snapshot
  • 6.2. Global Microneedle Flu Vaccine Market by Vaccine Type, Performance - Potential Analysis
  • 6.3. Global Microneedle Flu Vaccine Market Estimates & Forecasts by Vaccine Type, 2018-2028 (USD Million)
  • 6.4. Microneedle Flu Vaccine Market, Sub Segment Analysis
    • 6.4.1. Trivalent Flu Vaccine
    • 6.4.2. Quadrivalent Flu Vaccine

Chapter 7. Global Microneedle Flu Vaccine Market, by Product Type

  • 7.1. Market Snapshot
  • 7.2. Global Microneedle Flu Vaccine Market by Product Type, Performance - Potential Analysis
  • 7.3. Global Microneedle Flu Vaccine Market Estimates & Forecasts by Product Type, 2018-2028 (USD Million)
  • 7.4. Microneedle Flu Vaccine Market, Sub Segment Analysis
    • 7.4.1. Solid Microneedle
    • 7.4.2. Hollow Microneedle
    • 7.4.3. Coated Microneedle
    • 7.4.4. Dissolving Microneedle

Chapter 8. Global Microneedle Flu Vaccine Market, Regional Analysis

  • 8.1. Microneedle Flu Vaccine Market, Regional Market Snapshot
  • 8.2. North America Microneedle Flu Vaccine Market
    • 8.2.1. U.S. Microneedle Flu Vaccine Market
      • 8.2.1.1. Product Type breakdown estimates & forecasts, 2018-2028
      • 8.2.1.2. Vaccine Type breakdown estimates & forecasts, 2018-2028
    • 8.2.2. Canada Microneedle Flu Vaccine Market
  • 8.3. Europe Microneedle Flu Vaccine Market Snapshot
    • 8.3.1. U.K. Microneedle Flu Vaccine Market
    • 8.3.2. Germany Microneedle Flu Vaccine Market
    • 8.3.3. France Microneedle Flu Vaccine Market
    • 8.3.4. Spain Microneedle Flu Vaccine Market
    • 8.3.5. Italy Microneedle Flu Vaccine Market
    • 8.3.6. Rest of Europe Microneedle Flu Vaccine Market
  • 8.4. Asia-Pacific Microneedle Flu Vaccine Market Snapshot
    • 8.4.1. China Microneedle Flu Vaccine Market
    • 8.4.2. India Microneedle Flu Vaccine Market
    • 8.4.3. Japan Microneedle Flu Vaccine Market
    • 8.4.4. Australia Microneedle Flu Vaccine Market
    • 8.4.5. South Korea Microneedle Flu Vaccine Market
    • 8.4.6. Rest of Asia Pacific Microneedle Flu Vaccine Market
  • 8.5. Latin America Microneedle Flu Vaccine Market Snapshot
    • 8.5.1. Brazil Microneedle Flu Vaccine Market
    • 8.5.2. Mexico Microneedle Flu Vaccine Market
  • 8.6. Rest of The World Microneedle Flu Vaccine Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Becton, Dickinson and Company
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. 3M Company
    • 9.2.3. CosMED Pharmaceuticals Co., Ltd.
    • 9.2.4. OraSure Technologies, Inc.
    • 9.2.5. NanoPass Technologies Limited
    • 9.2.6. Corium International, Inc
    • 9.2.7. FluGen, Inc.
    • 9.2.8. Microdermics
    • 9.2.9. Debiotech S.A

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제